Seminar: “Current topics in Pharmacology and Theranostics“

Seminar room INO-F 703, Institute of Pharmacology

Date Time Name   Title Host 
Mar 1, 2017 12:15 Prof. Dr. Thanos Halazonetis, Department of Molecular Biology, University of Geneva Mechanisms of oncogene-induced DNA replication stress


G. Konstantinidou


Mar 22, 2017  12:15 Prof. Holger Stark, Dept. Pharmazeutische Chemie, Universität Düsseldorf

Histamine H3 Receptor Antagonists – From Bench to Bedside A New Medical Entity to Treat Narcolepsy A. Huwiler
Mar 29, 2017 12:15  Prof. Dr. Thierry Soldati, Department of Biochemistry, University of Geneva

Of amoebae and men: dissecting conserved cell-intrinsic defense mechanisms against infection

H.-U. Simon 
Apr 12, 2017
Prof. Dr. Mirjam Schenk, Institute of Pathologie, University of Bern

Induction of effective anti-tumour immunity by targeting dendritic cells

S. von Gunten
Apr 19, 2017 12:15 Prof. Dr. Donald Branch, University of Toronto and Canadian Blood Services (CAN) Repurposing Approved Drugs for Use in Ebola and HIV/AIDS S. von Gunten
Apr 26, 2017 12:15  Prof. Giulia Caron, Departments of Pharmacy and Molecular Biotechnology and Health Sciences, University of Turin (I) Ask not what you can do for discovering a new drug, ask what is still missing to do that G. Konstantinidou
Apr 28, 2017 9:00 Nikita Markov, visiting PhD student of Prof. Gerry Melino, Medical Council Research, Leicester, UK

REPS2 as a putative target of p73 transcription factor

H.-U. Simon  
May 3, 2017 12:15 Prof. Christophe Schlapbach, University Clinic for Dermatology, Inselspital Th9“ and Th2 cells: same same but different? H.-U. Simon 
May 10, 2017 12:15  Dr. Yury Belyaev, Microscopy Imaging Center and Institute of Anatomy, University of Bern  Huygens Remote Manager – web-based batch deconvolution for microscopy images S. Yousefi
July 5, 2017 12:15 Dr Ueli Nachbur, The Walter and Eliza Hall Instititue of Medical Research, Melbourne, Australia

How to target NOD signaling in inflammatory diseases T. Kaufmann 
Aug 29, 2017  9:15 Prof. Dr. Jan Klohs, Institute for Biomedical Engineering, University of Zurich and ETH Zurich Non-invasive imaging of the diseased brain: from microstructure to cellular events  H.-U. Simon
Sep 6, 2017 12:15

Dr. Carine Blanchard, Nestlé Research Center, Lausanne

Food allergy and eosinophilic esophagitis: genetics, epigenetics and nutrition

H.-U. Simon 
Sep 27, 2017 12:00 Prof. Luca Scorrano, Scientific Director, Venetian Institute of Molecular medicine, Padua (BIC Seminar)
This seminar take place at the Mik room at the institute of pathology

Keeping mitochondria in shape: a matter of life and death

H.-U. Simon 
Oct 10, 2017 16:00 Dr. Doriano Fabbro, PIQUR Therapeutics AG, Basel Targeted therapies for cancer: potentials and limitations A. Huwiler 
Oct 18, 2017 12:15 Prof. Renato Zenobi, Department of Chemistry and Applied Biosciences, ETH Zurich 

Exhalomics by Ambient Mass Spectrometry

Cédric Bovet

Nov 1, 2017 12:15  Prof. Bernd Bodenmiller, Institute of Molecular Life Sciences, University of Zurich

Highly multiplexed analysis of the tumor ecosystem by mass cytometry

Cédric Bovet

Nov 8, 2017 12:15  Prof. Etienne Meylan, ISREC, EPFL, Lausanne

Neutrophils and tumor cell SNAIL establish a vicious dialogue in lung adenocarcinoma

G. Konstantinidou 
Nov 28, 2017 12:15 Dorothea Fiedler, Professor in Chemical Biology, Director, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany Elucidating inositol pyrophosphate function with chemical tools G. Konstantinidou
Nov 29, 2017 12:15  Prof. Dr. Philipp Latzin, Klinik für Kinderheilkunde, Universität Bern BILD-cohort: a longitudinal birth cohort focusing on the development of airways and allergies H.-U. Simon 
Dez 14, 2017 14:00  Dr. Xavier Casadevall, Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich Single Cell Assays and Biomimetics for Pharmaceutical Research  H.-U. Simon 
Dez 20, 2017 14:00  Dr. Isabelle Arnold, Institute of Molecular Cancer Research, University of Zurich Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation   H.-U. Simon 
Jan 19, 2018  12:15  Prof. Dr. Daniel Hoessli, Panjwani Center for Molecular Medicine and Drug Design, University of Karachi, Pakistan Modulation of resistance to tyrosine kinase inhibitors H.-U. Simon 
Feb 14, 2018 12:15 PD Dr. Remo Perozzo, Senior Lecturer and Research Associate (MER), School of Pharmaceutical Sciences, University of Geneva Development of a novel bacterial three-hybrid system: A feasibility study H.-U. Simon  

Spnsored by:

AstraZeneca AG, Zug

Novartis Pharma Schweiz AG, Rotkreuz